Pmp22 Protein — Peripheral Myelin Protein 22 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PMP22 (Peripheral Myelin Protein 22, also known as Myelin Protein 22) is a 22-kDa tetraspan membrane protein encoded by the [PMP22 gene](/genes/pmp22). It is a major component of the peripheral nervous system myelin sheath, comprising approximately 2-5% of total myelin protein. The protein is essential for normal peripheral nerve function and is implicated in Charcot-Marie-Tooth disease.
Structure
PMP22 is a small tetraspan membrane protein with the following structural features:
Four transmembrane domains: Spanning the myelin membrane
Two extracellular loops: Important for protein-protein interactions
Intracellular N- and C-termini: Cytoplasmic domains involved in signaling
The protein adopts a compact structure that integrates into the lipid bilayer, contributing to the formation of the intraperiod line of compact myelin.
Normal Function
Myelin Formation and Maintenance
Myelin Assembly: PMP22 is incorporated into the compact myelin sheath, where it helps maintain structural integrity
Schwann Cell Function: Essential for proper Schwann cell differentiation and myelination
Protein Trafficking: Involved in transport of other myelin proteins
Myelin Stability: Maintains the integrity of the myelin sheath over time
Molecular Interactions
PMP22 interacts with several proteins in the myelin sheath:
Myelin Protein Zero (MPZ): Coordinated expression for proper myelination
Peripheral Myelin Protein 2 (PMP2): Co-localization in myelin
Integrins: Schwann cell adhesion and signaling
Role in Disease
Charcot-Marie-Tooth Disease Type 1A (CMT1A)
CMT1A is caused by duplication of the PMP22 gene region on chromosome 17p12, leading to:
Overexpression: 50% increase in PMP22 protein levels
The study of Pmp22 Protein — Peripheral Myelin Protein 22 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, The peripheral myelin protein 22 gene and Charcot-Marie-Tooth disease type 1A (2017)](https://doi.org/10.1093/brain/awx313)
[Unknown, PMP22: the magic widget of Charcot-Marie-Tooth disease (2019)](https://doi.org/10.1016/j.tins.2019.08.001)
[Unknown, ASO-based reduction of PMP22 attenuates demyelination and improves neuropathy phenotypes (2019)](https://doi.org/10.1093/brain/awz380)
[Unknown, Structure of the peripheral myelin protein 22 (2018)](https://doi.org/10.1016/j.jmb.2018.06.015)
[Unknown, Charcot-Marie-Tooth disease and related disorders (2020)](https://doi.org/10.1212/WNL.0000000000006932)